Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

PRP therapy helps heal pediatric surgical wounds faster and with fewer scars but needs more research for safety and cost.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Minoxidil effectively treats female pattern hair loss.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

New treatments for lupus show promise, but more research is needed, especially for children.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.